Business Segments · Identifiable assets
Biotechnology — Identifiable assets
Danaher Biotechnology — Identifiable assets increased by 0.1% to $37.34B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.9%, from $34.61B to $37.34B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2020
Last reportedQ4 2025
Rolls up toTotal Assets
How to read this metric
High asset levels relative to revenue may suggest lower asset turnover efficiency.
Detailed definition
The total value of assets that can be directly attributed to the biotechnology segment, including inventory, property, p...
Peer comparison
Standard segment reporting requirement for public companies.
Metric ID:
dhr_segment_biotechnology_identifiable_assetsHistorical Data
8 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $38.12B | $37.54B | $37.42B | $34.61B | $36.12B | $37.56B | $37.30B | $37.34B |
| QoQ Change | — | -1.5% | -0.3% | -7.5% | +4.4% | +4.0% | -0.7% | +0.1% |
| YoY Change | — | -1.5% | -0.3% | -7.5% | — | — | — | +7.9% |
Range$34.61B – $38.12B
CAGR-1.2%
Avg YoY Growth-0.4%
Median YoY Growth-0.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — identifiable assets?
- Danaher (DHR) reported biotechnology — identifiable assets of $37.34B in Q4 2025.
- How has Danaher's biotechnology — identifiable assets changed year-over-year?
- Danaher's biotechnology — identifiable assets increased by 7.9% year-over-year, from $34.61B to $37.34B.
- What does biotechnology — identifiable assets mean?
- The total value of assets specifically used by the biotechnology segment.